Uechi L, Vasudevan S, Vilenski D, Branciamore S, Frankhouser D, OMeally D
NPJ Syst Biol Appl. 2024; 10(1):32.
PMID: 38527998
PMC: 10963775.
DOI: 10.1038/s41540-024-00352-6.
Alves-Hanna F, Crespo-Neto J, Nogueira G, Pereira D, Lima A, Ribeiro T
J Immunol Res. 2023; 2023:5584492.
PMID: 37577033
PMC: 10421713.
DOI: 10.1155/2023/5584492.
Luciano M, Krenn P, Horejs-Hoeck J
Front Immunol. 2022; 13:1000996.
PMID: 36248849
PMC: 9554002.
DOI: 10.3389/fimmu.2022.1000996.
Urwanisch L, Luciano M, Horejs-Hoeck J
Int J Mol Sci. 2021; 22(3).
PMID: 33525345
PMC: 7865748.
DOI: 10.3390/ijms22031271.
Azab E, Chandler K, Uda Y, Sun N, Hussein A, Shuwaikan R
FASEB J. 2020; 34(8):10191-10211.
PMID: 32557809
PMC: 7688590.
DOI: 10.1096/fj.202000366R.
Identification of DNA methylation prognostic signature of acute myelocytic leukemia.
Zhang H, Song G, Song G, Li R, Gao M, Ye L
PLoS One. 2018; 13(6):e0199689.
PMID: 29933410
PMC: 6014658.
DOI: 10.1371/journal.pone.0199689.
IMMUNOBIOLOGICAL MONITORING OF VARIOUS GASTROINTESTINAL AND PRIMARY HEPATIC MALIGNANCIES.
Chopra G, Mishra K, Vohra L, Jaiprakash M, Bhardwaj J
Med J Armed Forces India. 2017; 53(3):178-182.
PMID: 28769480
PMC: 5530982.
DOI: 10.1016/S0377-1237(17)30711-6.
Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid Leukemia.
Carey A, Edwards 5th D, Eide C, Newell L, Traer E, Medeiros B
Cell Rep. 2017; 18(13):3204-3218.
PMID: 28355571
PMC: 5437102.
DOI: 10.1016/j.celrep.2017.03.018.
Sensitizing leukemia stem cells to NF-κB inhibitor treatment in vivo by inactivation of both TNF and IL-1 signaling.
Li J, Volk A, Zhang J, Cannova J, Dai S, Hao C
Oncotarget. 2017; 8(5):8420-8435.
PMID: 28039479
PMC: 5352411.
DOI: 10.18632/oncotarget.14220.
Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia.
Agerstam H, Karlsson C, Hansen N, Sanden C, Askmyr M, von Palffy S
Proc Natl Acad Sci U S A. 2015; 112(34):10786-91.
PMID: 26261316
PMC: 4553807.
DOI: 10.1073/pnas.1422749112.
A novel way to get out of the cell.
Rubartelli A, Bajetto A, Bonifaci N, Di Blas E, Solito E, Sitia R
Cytotechnology. 2012; 11(Suppl 1):S37-40.
PMID: 22358704
DOI: 10.1007/BF00746049.
The NLRP3 inflammasome in health and disease: the good, the bad and the ugly.
Menu P, Vince J
Clin Exp Immunol. 2011; 166(1):1-15.
PMID: 21762124
PMC: 3193914.
DOI: 10.1111/j.1365-2249.2011.04440.x.
Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Schwind S, Maharry K, Radmacher M, Mrozek K, Holland K, Margeson D
J Clin Oncol. 2010; 28(36):5257-64.
PMID: 21079133
PMC: 3018359.
DOI: 10.1200/JCO.2010.29.2953.
Interactions between rnacrophage cytokines and eicosanoids in expression of antitumour activity.
Ben-Efraim S
Mediators Inflamm. 1992; 1(5):295-308.
PMID: 18475475
PMC: 2365362.
DOI: 10.1155/S0962935192000449.
The role of VEGF in normal and neoplastic hematopoiesis.
Gerber H, Ferrara N
J Mol Med (Berl). 2003; 81(1):20-31.
PMID: 12545246
DOI: 10.1007/s00109-002-0397-4.
1,25-Dihydroxyvitamin D3 and its analogues inhibit acute myelogenous leukemia progenitor proliferation by suppressing interleukin-1beta production.
Peleg S, Qiu H, Reddy S, Harris D, Van Q, Estey E
J Clin Invest. 1997; 100(7):1716-24.
PMID: 9312169
PMC: 508354.
DOI: 10.1172/JCI119696.
Cytokine production by a megakaryocytic cell line.
Sandrock B, Hudson K, Williams D, Lieberman M
In Vitro Cell Dev Biol Anim. 1996; 32(4):225-33.
PMID: 8727047
DOI: 10.1007/BF02722950.
Characterization of a novel Hodgkin cell line, HD-MyZ, with myelomonocytic features mimicking Hodgkin's disease in severe combined immunodeficient mice.
Bargou R, Mapara M, Zugck C, Daniel P, Pawlita M, Dohner H
J Exp Med. 1993; 177(5):1257-68.
PMID: 8386741
PMC: 2191008.
DOI: 10.1084/jem.177.5.1257.
c-KIT expression enhances the leukemogenic potential of 32D cells.
Hu Q, Trevisan M, Xu Y, Dong W, Berger S, Lyman S
J Clin Invest. 1995; 95(6):2530-8.
PMID: 7539453
PMC: 295935.
DOI: 10.1172/JCI117954.
In vitro effect of r-verapamil on acute myelogenous leukemia blast cells: studies of cytokine secretion and cytokine-dependent blast proliferation.
Bruserud O, Nesthus I, Pawelec G
Cancer Chemother Pharmacol. 1995; 37(1-2):70-8.
PMID: 7497600
DOI: 10.1007/BF00685631.